|

Pramipexole ER Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • National Institute of Allergy and Infectious Diseases (NIAID)1

Indications

  • Mild Neurocognitive Disorder1
  • Major Depressive Disorder1
  • HIV1
  • Depression1

Birmingham, Alabama1 trial

Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV

Alabama CRS

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.